Skip to content

Comparison of anesthesia effects of different doses of esketamine combined with propofol in painless electronic gastroscopy

Comparison of anesthesia effects of different doses of esketamine combined with propofol in painless electronic gastroscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038599
Enrollment
Unknown
Registered
2020-09-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastrointestinal endoscopy

Interventions

Group E0:Direct injection of propofol 3µg/mL via TCI
Group E1:After administering 0.125 mg/kg of dextro-ketamine for 1 min, inject propofol 3 µg/mL via TCI
Group E2:After administering 0.25mg/kg of dextro-ketamine for 1 min, inject propofol 3 µg/mL via TCI
Group E3:After administering 0.5mg/kg of dextro-ketamine for 1 min, inject propofol 3 µg/mL via TCI

Sponsors

Nanchong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II; 2. Aged 18 to 65 years old; 3. BMI 20 to 28; 4. Adult patients who intend to undergo painless electronic gastroscopy; 5. Have an education level of junior high school or above to complete the neuropsychological test.

Exclusion criteria

Exclusion criteria: 1. History of drug abuse; 2. Patients with hypertension 3. Patients with elevated intracranial pressure and intraocular pressure; 4. Patients with upper gastrointestinal bleeding; 5. Patients with apnea syndrome; 6. Patients with diabetes history; 7. Patients with severe respiratory and cardiovascular system history; 8. Patients with neurological or mental illnesses or previous cognitive impairment; 9. Pregnancy; 10. Patients with impaired liver and kidney function; 11. Patients who are known to be allergic to propofol, etc. and who are expected to have difficulty in intubating the trachea.

Design outcomes

Primary

MeasureTime frame
Modified Aldrete score;VAS pain score;MMSE;Inducing dose of propofol;Supplemental dose of propofol;Total amount of propofol;Rate of body movement;Cough incidence;Gastroscopy time;Wake up time;

Countries

China

Contacts

Public ContactWang Han

Nanchong Central Hospital

45107137@qq.com+86 13990878757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026